Plant Health Care Share Discussion Threads

[cerrito] 03/1/2021 23:55

I just got round to listening to the Inverstor Meets Company presentation...some good q&a.
One issue is if they do not get approval from the Federal authorities in Brazil to allow PHC279 to be launched for the 21/22 growing season, especially as they still have to sign up a distributor and manufacturer and neither will want to invest time and money until they can get themselves comfortable that approval will be forthcoming. Do any of you share my concern at their not being able to be fully up and running for the 21/22 season?
As someone who was in PIM there was a sense of deja vu in discussing the asian rust disease. If I had listened to it live and thus been able to ask questions, I would have asked what if anything they took away from the PIM experience.
I am not into Croda so cannot comment on what they have been doing with Brazilian soya.
Waiting for the end of month TU with its renewed guidance for what 2021 should bring.

[apollocreed1] 20/12/2020 07:17

@Dubai123 - In my opinion, this stock has primarily suffered from growing revenue but equally growing losses, and therefore having to dilute shareholders by raising more money from the market quite regularly.

[dubai123] 19/12/2020 14:59

Just watched the presentation as it is Ondemand. Pretext seems very exciting having had $20 million invested to date with majors in the industry now signing deals with them. Let's not forget the core harpin business is a great place also. This stock has suffered from a lack of awareness so as soon as investors see the opportunity here I suspect we will see further progress

[apollocreed1] 18/12/2020 12:18

Is the upwards move on no news flow potentially insiders buying in insider news? Or is it due to an analyst presentation as mentioned above? That presentation is not mentioned in the RNS

I noticed Synairgen shares moving up strongly this week but the real news only came out today, so I see a similar pattern here

[pugugly] 17/12/2020 15:49

Very useful presentation on Investor meet Company.

[loafofbread] 10/12/2020 17:22

Something going on here.

Take over finally on it's way?

[callumross] 07/12/2020 17:08

Potential here at last

[1pencil] 29/10/2020 16:57

Pass the hat time..

[1pencil] 07/10/2020 08:25

Awarding options with a strike price of 1p.

"The Company has awarded 6.5m options with an exercise price of 1p per share under the Plan (representing 2.58% of the Company's current issued share capital)"

[1pencil] 06/10/2020 21:41

I would rather they did a video to explain how they missed guidance this year, on top of that raising additional funds (twice), once in Nov then again in Feb.

If you haven't done so already its worth watching the videos from last year along with press statements, also read investors comments during this period.

Its been on my watch list for sometime, but need to further understand managements past decisions on forward guidance.

From 30th Sept 2019 Interim Results

"The Commercial business is forecast to be profitable and cash generative in 2019, with profitable growth continuing in future years. The Board is committed to achieving cash breakeven within existing resources and will take the necessary steps to achieve it."

[cerrito] 06/10/2020 20:50

No idea I am afraid 1pencil.
I am sure you have all heard the presentation on Investor meets Company and if you have not strongly suggest you do so.
There was a statement in the RNS this morning that confused me: Richards talked of pretec products being commercialized in 2022 but in the presentation he said the idea is to have PHC279 ready for the October 21 Brazil sugar cane crop.
Is anyone else confused?

[1pencil] 06/10/2020 15:16

Does anyone know if Edison are still covering Plant Healthcare?

Currently listed as investor contact but so far no response.

[cerrito] 04/10/2020 09:58

Just caught up with the midweek news from Bayer reducing expectations from their agricultural sciences division for the rest of this year and next because of Covid related issues.
I need yo work out the see through to PHC.
Any views?

[cerrito] 29/7/2020 08:05

At first glance all good with increase in sales and gross margin compared to H1 19 and reduction in expenses and cash used in operations. However note that Cash used in operations at us2.1m in H1 20 was higher than the 1.5m in H2 19.
I see that it was a half of two quarters although the difficulties in Q2 were well highlighted in the Outlook section of the 2019 results statement..
Will be interesting to know how the Labour situation in the US fruit business was resolved.

[loafofbread] 29/7/2020 07:42

Decent update.

[cerrito] 16/6/2020 21:25

Anyone understand what ius the position ref UK authorization given the tests going on in the UK as per May 27 RNS.
I appreciate UK small market compared to US/Brazil but begs the question on EU approvals.

[jakes114] 16/6/2020 09:14

Great news 14p here we come and once approval is obtained for Brazil whey hey

[ny boy] 27/5/2020 09:50

(PPS) another great recovery play too

[colin12345678] 27/5/2020 09:29

Highlights:



US Corn

- PHC 279 increased corn yields by 9-15% when applied as a foliar spray, creating potential grower value of $54 - $82 per acre at current average prices.

- PHC279 significantly improved the control of two key corn diseases by as much as 50%, even under heavy disease pressure.

Spring wheat

- PHC279 increased yield by as much as 17% when added to the standard disease control program, which is worth $86 per acre at current prices.

Lettuce

- PHC279 increased yield by as much as 22% compared to fungicides alone.

- PHC279 also improved disease control as much as 31% following foliar application.



In the US, 91m acres of corn were planted in 2019. Severe southern rust disease can routinely reduce corn yields as much as 25 bushels per acre. At current prices, this would equate to lost revenue for the farmer of $79 per acre. In historical epidemics of southern corn leaf blight, yields were reduced by 20 to 25 percent nationwide, resulting in an estimated $1 billion loss in harvest. In the Company's trials, when PHC279 was applied together with a leading chemical fungicide, it significantly improved control of both diseases compared to the fungicide treatment alone, and yields were increased by as much as 26 bushels per acre depending on application timing. Even a more modest benefit of 5-10 bushels per acre is likely to provide an attractive return on investment in the potential range of 5:1 to 8:1 for farmers who apply PHC279 to their fields.



In the UK, when PHC279 was applied to spring wheat seeds prior to planting, followed by adding it to the standard spray fungicide program, yield was increased by as much as 17% in fields with Septoria tritici blotch, the major disease of wheat in the UK. At current prices, this yield benefit would be worth $86 per acre to the farmer.



Lettuce drop disease is a major pathogen affecting US lettuce cultivation. In a series of US field trials inoculated with Sclerotinia, the causative agent of lettuce drop disease, PHC279 treated plants yielded as much as 22% more than plants treated only with the standard chemical fungicide program. With an acre of lettuce worth more than $10,000 in the US in 2018, even a modest increase in lettuce yield will likely justify the cost of applying PHC279.



Plant Health Care's PREtec peptides stimulate the plant to defend itself. Derived from natural proteins, this is a novel, environmentally friendly approach to protecting crops and increasing yields, compatible with mainstream agricultural practice. PHC279 may allow farmers to reduce applications of toxic fungicides or to achieve better control of disease.



Gary L. Cloud, Ph.D., a research agronomist and owner of GLC Consulting, Inc. participated in the testing of PHC279 in corn this season, and offered the following, "There was heavy disease pressure and PHC279 provided visible improvement in disease control and higher yield compared to the standard fungicide when applied early in the growing season. That is somewhat amazing due to the time that elapsed between application and harvest. I believe PHC279 will be a valuable tool for corn growers struggling to control disease in their fields."



Chris Richards, CEO of Plant Health Care, said "We are extremely encouraged with the performance of PHC279 in multiple key crops. Building on our recent success with PHC279 for the control of Asian soybean rust in Brazil, it is clear PHC279 will have important benefits for farmers in many crops. The registration of our first PREtec peptide is progressing in the US and Brazil and the scale-up of manufacturing has started. We are excited about the potential for products based on our PREtec peptides, which are targeting markets with an initial opportunity of $5 billion. We aim to launch the first peptides as soon as regulatory permits have been obtained, to offer these valuable new tools to growers in the US and other countries."

[ny boy] 27/5/2020 09:21

Impressive to say the least, still a long term hold here for me 100p +

[twozuluzulu] 27/5/2020 09:05

flying.
mm upped bid by 42%

[loafofbread] 27/5/2020 08:28

Pretty good trial results today.

Happy to wait for the eventual rerate.

[cerrito] 11/5/2020 14:33

I listened to the Edison TV interview with Dr Richards and went through the prelins in a bit more depth.
He reiterated what they said in the prelims ie that even in the worst case scenario they had cash till early 2022.
Note the March 21 RNS referred to approvals for PHC 279 but I could see no reference to that in the prelims.
I need to say that on further reflection I have got confused about how strong sales will be in 2020 given Brazil ethanol and also US fruit industry with both labour issues and disappearance of restaurant trade,
A slow burn but at least they have plenty of cash.